Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Sarepta Therapeutics, Inc. | 440,307 | reported | 07 Dec 2025 | tx 23+4,358,478−129,087 |
| Skye Bioscience, Inc. | 372,500 | reported | 20 Oct 2015 | tx 4+412,500−100,000 |
| Relay Therapeutics, Inc. | 136,681 | reported | 06 Jun 2025 | tx 6+387,558 |
| ARROWHEAD PHARMACEUTICALS, INC. | 46,215 | reported | 16 Dec 2025 | tx 2+46,215 |
| Endo International plc | 28,824 | reported | 09 Jun 2017 | tx 5+42,740−16,001 |
| ALLERGAN INC | 0 | reported | 17 Mar 2015 | tx 93+1,768,443−2,217,255.05 |
| Volcom Inc | 0 | reported | 23 Jun 2011 | tx 15+20,500−23,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Dec 2025 | GRANT_AWARD | ARROWHEAD PHARMACEUTICALS, INC. | 7,819 | 0.00 USD | |
| 07 Dec 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 73,001 | 0.00 USD | |
| 07 Dec 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 50,000 | 0.00 USD | |
| 07 Dec 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 50,000 | 0.00 USD | |
| 07 Dec 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 269,542 | 0.00 USD | |
| 07 Dec 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 96,541 | 0.00 USD | |
| 06 Jun 2025 | GRANT_AWARD | Relay Therapeutics, Inc. | 136,681 | 0.00 USD | deriv |
| 06 Feb 2025 | GRANT_AWARD | ARROWHEAD PHARMACEUTICALS, INC. | 38,396 | 20.09 USD | |
| 03 Jun 2024 | GRANT_AWARD | Relay Therapeutics, Inc. | 102,225 | 0.00 USD | deriv |
| 03 Nov 2023 | PURCHASE | Sarepta Therapeutics, Inc. | 200 | 81.26 USD | |
| 03 Nov 2023 | PURCHASE | Sarepta Therapeutics, Inc. | 11,060 | 79.70 USD | |
| 03 Nov 2023 | PURCHASE | Sarepta Therapeutics, Inc. | 10,081 | 78.57 USD | first after silence |
| 03 Nov 2023 | PURCHASE | Sarepta Therapeutics, Inc. | 3,884 | 80.33 USD | |
| 31 May 2023 | GRANT_AWARD | Relay Therapeutics, Inc. | 66,055 | 0.00 USD | deriv |
| 27 May 2022 | GRANT_AWARD | Relay Therapeutics, Inc. | 41,597 | 0.00 USD | deriv |
| 17 Nov 2021 | PURCHASE | Sarepta Therapeutics, Inc. | 25,026 | 79.94 USD | first after silence |
| 26 Jun 2021 | TAX_WITHHOLDING | Sarepta Therapeutics, Inc. | 17,812 | 80.40 USD | |
| 19 May 2021 | GRANT_AWARD | Relay Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 31 Dec 2020 | TAX_WITHHOLDING | Sarepta Therapeutics, Inc. | 37,144 | 170.49 USD | |
| 20 Jul 2020 | PURCHASE | Relay Therapeutics, Inc. | 25,000 | 20.00 USD | |
| 31 Dec 2019 | TAX_WITHHOLDING | Sarepta Therapeutics, Inc. | 37,185 | 129.04 USD | |
| 12 Aug 2019 | PURCHASE | Sarepta Therapeutics, Inc. | 7,792 | 123.41 USD | |
| 12 Aug 2019 | PURCHASE | Sarepta Therapeutics, Inc. | 8,460 | 122.76 USD | |
| 30 Oct 2018 | PURCHASE | Sarepta Therapeutics, Inc. | 13,561 | 120.26 USD | |
| 30 Oct 2018 | PURCHASE | Sarepta Therapeutics, Inc. | 3,134 | 120.94 USD |
3 purchases reported after at least 12 months of silence — most recent on 03 Nov 2023.